As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient ...

With all doses of FDA-approved Wegovy ® fully available nationwide ... permitted to manufacture "semaglutide" for use in drugs in China. However, they are exporting this "semaglutide" into ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

In addition to voluntary pledges, WHO member states last year approved an increase in assessed contributions. This year also, ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

The billionaire investor is not hopeful politicians will be able to reconcile their differences and lessen the country’s debt ...

Amgen’s AMGN stock has declined 10.4% in the past three months. A lot of this price decline is related to the broader ...

The U.S. Department of Justice took control of Lumma's "central command structure" and squashed the online marketplaces where bad actors purchased the malware.

[Photo/Agencies] Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and obese adults reached almost ...